language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
UNHUNH

$334.47

-4.59
arrow_drop_down1.35%
Current Market·update13 Nov 2025 16:02
Day's Range
331.791-339.03
52-week Range
234.6-622.83

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2025-10-28
Next Earnings TimeBefore Market Open
Volume2.94M
Average Volume 30d12.62M

AI UNH Summary

Powered by LiveAI
💰
14.1
Valuation (P/E Ratio)
The current P/E ratio is 14.1, which is considered reasonable within its sector.
📈
0.152
EPS Growth (YoY)
Year-over-year EPS growth of 15.2% indicates strong earnings performance.
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Buy
75

UnitedHealth Group demonstrates strong fundamental performance and positive long-term thematic alignment in the healthcare sector. While recent technical indicators suggest a short-term consolidation, the overall outlook remains favorable for investors seeking stability and growth.

Very Strong

Thematic

85

UNH is well-positioned to benefit from demographic trends, increasing healthcare utilization, and the expansion of its diversified business segments (UnitedHealthcare, Optum).

Strong

Fundamental

80

UNH exhibits robust financial health with consistent revenue growth, strong profitability, and a manageable debt level. Its valuation metrics are generally in line with its growth prospects.

Neutral

Technical

65

The stock has experienced a significant decline, trading below key moving averages. While some oscillators suggest potential oversold conditions, the immediate trend remains bearish.

FactorScore
Healthcare Sector Growth90
Diversified Business Model92
Innovation in Health Technology85
Regulatory Landscape75
Market Penetration83
FactorScore
Valuation85
Profitability78
Growth82
Balance Sheet Health70
Cash Flow88
FactorScore
Trend Analysis40
Momentum50
Volume Confirmation65
Support & Resistance70

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (7)

Earnings Performance chevron_right

Consistent Earnings Surprises

UnitedHealth Group (UNH) has consistently beaten EPS estimates in the last 12 quarters, with an average surprise of 4.07%. This demonstrates strong operational execution and reliable earnings generation.

Valuation chevron_right

Attractive Forward P/E Ratio

The forward P/E ratio of 11.66 is significantly lower than its historical average and suggests that the stock may be undervalued relative to its future earnings potential.

Show More 🔒
thumb_down

Bearish Points (7)

Valuation Risk chevron_right

Elevated Price-to-Sales Ratio

The trailing Price-to-Sales (P/S) ratio of 0.8, while seemingly low, needs to be considered in context of the industry and growth prospects. A higher P/S might suggest high market expectations.

Growth Deceleration chevron_right

Slowing Revenue Growth in Latest Quarter

Revenue growth in the latest quarterly report (e.g., Q1 2025 revenue $109.575 billion) shows a net margin of 5.7%, which is a decrease from the previous quarter's 6.0% (Q4 2024), signaling potential margin pressure.

Show More 🔒

Calendar

June 2025

16

Ex-Dividend Date

June 2025

24

Next Dividend Date

July 2025

29

Next Earnings Date

EPS Est.
Revenue Est.

H: $5.48

A: $4.49

L: $3.69

H: 115.06B

A: 111.59B

L: 109.21B

Profile

Employees (FY)400K
ISIN-
FIGI-

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older; Medicaid plans, children's health insurance and health care programs; and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.

Seasonals

2025
2024
2023
2022
2021

Price Target

379.34 USD

The 39 analysts offering 1 year price forecasts for UNH have a max estimate of 626.00 and a min estimate of 270.00.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
905M (99.71%)
Closely held shares
2.64M (0.29%)
907M
Free Float shares
905M (99.71%)
Closely held shares
2.64M (0.29%)

Capital Structure

Market cap
252.71B
Debt
76.9B
Minority interest
0.00
Cash & equivalents
25.31B
Enterprise value
304.3B

Valuation - Summary

Market Cap
253B
Net income
17.9B(7.08%)
Revenue
311B(123.15%)
253B
Market Cap
253B
Net income
17.9B(7.08%)
Revenue
311B(123.15%)
Price to earning ratio (P/E)14.10x
Price to sales ratio (P/S)0.80x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
400.28B
COGS
310.88B
Gross Profit
89.4B
OpEx
57.11B
Operating Income
32.29B
Other & Taxes
17.88B
Net Income
14.4B

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒